David Roblin

In 2012, Jack Scannell, a pharma industry expert, coined the term “EROOM’s law.” This was a vivid way to contrast the declining rate of productivity in drug discovery with the rapid acceleration in computing power that became known after the 1960s as Moore’s law. Eroom’s law stated that the number of new drugs approved per billion US dollars spent on... Read More